Rapport Therapeutics Inc (RAPP)

Dec 20, 2024

When (RAPP) Moves Investors should Listen - Stock Traders Daily

Dec 20, 2024

Dec 20, 2024

1,684 Shares in Rapport Therapeutics (NASDAQ:RAPP) Bought by BNP Paribas Financial Markets - Defense World

Dec 20, 2024

Dec 19, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.6%Should You Sell? - MarketBeat

Dec 19, 2024

Dec 18, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.7%Should You Buy? - MarketBeat

Dec 18, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Buys New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Dec 17, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Dec 17, 2024

Dec 10, 2024

CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors - The Manila Times

Dec 10, 2024

Dec 09, 2024

(RAPP) Proactive Strategies - Stock Traders Daily

Dec 09, 2024

Dec 07, 2024

Companies Like Rapport Therapeutics (NASDAQ:RAPP) Can Afford To Invest In Growth - Simply Wall St

Dec 07, 2024

Dec 07, 2024

We're Not Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn - Yahoo Finance

Dec 07, 2024

Dec 06, 2024

Rapport Therapeutics Presents Data Demonstrating Consistent - GlobeNewswire

Dec 06, 2024

Dec 06, 2024

Rapport Therapeutics Breakthrough: New Epilepsy Treatment Biomarker Shows Strong Clinical Seizure Correlation | RAPP Stock News - StockTitan

Dec 06, 2024

Dec 05, 2024

Maven Securities LTD Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Fmr LLC Raises Stock Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Dec 05, 2024

Nov 27, 2024

Rapport Therapeutics' Lock-Up Period To Expire on December 4th (NASDAQ:RAPP) - MarketBeat

Nov 27, 2024

Nov 27, 2024

Rapport Therapeutics’ Lock-Up Period Will Expire on December 4th (NASDAQ:RAPP) - Defense World

Nov 27, 2024

Nov 21, 2024

Two new option listings and one option delisting on November 21st - TipRanks

Nov 21, 2024

Nov 20, 2024

Rapport Therapeutics Reports Q3 Financials and Strategic Updates - MSN

Nov 20, 2024

Nov 20, 2024

LMR Partners LLP Sells 30,000 Shares of Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Nov 20, 2024

Nov 18, 2024

(RAPP) Investment Analysis and Advice - Stock Traders Daily

Nov 18, 2024

Nov 17, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 6.5% – Should You Sell? - Defense World

Nov 17, 2024

Nov 15, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%Time to Sell? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Cormorant Asset Management's Strategic Acquisition in Rapport Th - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Rapport Therapeutics to Present Phase 2a Epilepsy Drug Data at Major Conference | RAPP Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition in Rapport Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more - BioSpace

Nov 12, 2024

Nov 11, 2024

Cartesian Therapeutics (NASDAQ:RNAC) & Rapport Therapeutics (NASDAQ:RAPP) Head to Head Comparison - Defense World

Nov 11, 2024

Nov 09, 2024

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 09, 2024

Nov 07, 2024

(RAPP) Investment Report - Stock Traders Daily

Nov 07, 2024

Nov 07, 2024

Rapport Therapeutics Inc (RAPP) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update - The Manila Times

Nov 07, 2024

Nov 07, 2024

Rapport (RAPP) Hit With FDA Hold Despite $320M Cash Position; Q3 Loss Widens | RAPP Stock News - StockTitan

Nov 07, 2024

Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare - GlobeNewswire

Nov 04, 2024

Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - StockTitan

Nov 04, 2024

Nov 03, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Still a Buy? - Defense World

Nov 03, 2024

Nov 01, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Nov 01, 2024

Oct 28, 2024

SG Americas Securities LLC Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Oct 28, 2024

Oct 28, 2024

(RAPP) Trading Report - Stock Traders Daily

Oct 28, 2024

Oct 25, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 4.2%Here's Why - MarketBeat

Oct 25, 2024

Oct 21, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownShould You Sell? - MarketBeat

Oct 21, 2024

Oct 19, 2024

Jones Trading Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - MSN

Oct 19, 2024

Oct 18, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.7%Time to Sell? - MarketBeat

Oct 18, 2024

Oct 18, 2024

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - MSN

Oct 18, 2024

Oct 16, 2024

Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year HighTime to Buy? - MarketBeat

Oct 16, 2024

Oct 16, 2024

Millennium Management LLC Makes New $2.72 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Oct 16, 2024

Oct 15, 2024

Rapport Therapeutics (NASDAQ:RAPP) Short Interest Up 32.4% in September - MarketBeat

Oct 15, 2024

Oct 14, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.3%What's Next? - MarketBeat

Oct 14, 2024

Oct 11, 2024

75,516 Shares in Rapport Therapeutics (NASDAQ:RAPP) Purchased by The Manufacturers Life Insurance Company - MarketBeat

Oct 11, 2024